OSMR β Antibodies

Santa Cruz Biotechnology provides a broad selection of OSMR β monoclonal antibodies for investigating oncostatin M receptor (OSMR) in various biological processes. OSMR β monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The oncostatin M receptor plays a central role in signaling pathways that regulate inflammation, cell differentiation, and tissue remodeling. OSMR has been identified as a key factor in multiple diseases, including cancer and autoimmune disorders. Understanding OSMR function is essential for developing targeted therapeutic strategies. Researchers can explore OSMR's cellular distribution, protein interactions, and expression patterns through multiple experimental approaches. OSMR β monoclonal antibodies enable precise detection and quantification of OSMR in diverse sample types. Current research continues to uncover new roles for OSMR in cellular signaling and disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of OSMR biology and its therapeutic potential.